Amyotrophic Lateral Sclerosis (ALS) Continuing Education Module
Course: WB 4149
CE Original Date: November 15, 2018
CE Expiration Date: November 15, 2020
This project will provide an overall of ALS to include its clinical applications, diagnosis, treatment, management, educational and its importance in getting a registry stated and maintained. The launching of the ALS Registry module is needed to educate the health care providers so they can inform their patients on the requirements for registering and participating in the program.
At the conclusion of the session, the participant will be able to:
- Define ALS.
- Describe the epidemiology of ALS.
- Identify risk factors for ALS.
- Describe different classifications of ALS.
- Describe potential etiologies of ALS.
- Describe clinical manifestations of ALS.
- Describe how the National ALS Registry will impact my teams’ knowledge/competency of ALS in the U.S
To access and begin the ALS Registry module, please visit the ALS Registry online training module.
Individuals with disabilities may have difficulty completing the course. If you need assistance, please contact Tom Hicks at firstname.lastname@example.org and mention you need assistance with the ATSDR Amyotrophic Lateral Sclerosis (ALS) Registry Online Training Module.
This course is provided as part of the National ALS Registry. For information regarding the National ALS Registry, please visit https://www.cdc.gov/als/
Paul Mehta MD, Principal Investigator of the National ALS Registry
Who is this training for?
Our primary target audience is primary health providers and other health professionals involved in preventing/mitigating exposure to hazardous substances and/or related health promotion activities. The target populations for the ALS are pediatric health care providers, primary health care providers and other health professionals that are interested in environmental health topics; which include: CHES certified health educator; dentists; D.O.s; Epidemiologists; Laboratorians: Licensed practical/vocational nurses; MDs; Medical assistants; Nurse practitioners; Nurse technicians; Other health educators; Physician assistants; Registered nurses; Physicians.
What is this training about?
ALS is a rapidly progressive neuro-degenerative disease. It belongs to a group of disorders known as motor neuron diseases, which are characterized by the gradual degeneration and death of motor neurons. These diseases cause loss of ability to trigger specific muscles, which results in the muscles becoming weak and ultimately leading to paralysis. This educational module provides:
- A clinical overview on ALS
- Current clinical practice recommendations for diagnosis, treatment, and management of patients with ALS, including communication strategies
- Information on the importance of standard diagnostic coding procedures for diagnosis of ALS patients in clinical practice
- Information on the new National ALS Registry and the importance of ALS patient self-enrollment in the registry
Who developed this continuing education training?
ATSDR’s Division of Toxicology and Human Health Sciences collaboratively developed this online continuing education module.
Acknowledgement of external course contributors and reviewers
ATSDR acknowledges and gives special thanks to Eric Sorenson M.D. and David J. Thurman, MD, MPH, FAAN for their assistance in the development and review of the module. We also acknowledge those who provided formative review and testing of the educational module:
- Richard D. Franco M.D. (Board certified in Internal Medicine and Neurology)
- Matthews Gwynn M.D. (Board certified in Internal Medicine and Neurology)
- Rebecca Heitkam RN, BSN, CCRN
- Lisa Johnson M.D. (Board certified in Neurology and Sleep Disorders)
- Barry McCasland M.D. (Board certified in Neurology)
- Alex Rikhter M.D. (Board certified in Internal Medicine)
- Keith Sanders M. D. (Board certified in Neurology and Electrodiagnostic Medicine)
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 1.1 contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credits for this program.
To receive free continuing education, you must complete the activity and evaluation as well as pass the posttest at 75%.
For more information and access to all continuing education offerings, please visit https://www.cdc.gov/GetCE.
FEES: No fees are charged for CDC’s CE activities.
Training Module Information
A basic knowledge of medicine or related basics of human health promotion at a professional level is desired
The participant will need access to a computer with internet access and a printer to print out the certificate of completion once training is completed
Disclaimer and Disclosure
In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
For additional information about Environmental Medicine Education Products, please email email@example.com.